A Randomized, 12-Year Primary-Prevention Trial of Beta Carotene Supplementation for Nonmelanoma Skin Cancer in the Physicians' Health Study
Open Access
- 1 February 2000
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 136 (2) , 179-184
- https://doi.org/10.1001/archderm.136.2.179
Abstract
BASAL CELL carcinoma (BCC) and squamous cell carcinoma (SCC), usually referred to as nonmelanoma skin cancer (NMSC), are the most common malignant neoplasms among white patients. Worldwide, including in the United States, the incidence of NMSC is increasing.1,2 Although NMSC has an extremely low case fatality rate, it is a major cause of morbidity, including notable disfigurement, particularly as most lesions occur on the face, head, or neck.3Keywords
This publication has 3 references indexed in Scilit:
- The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male SmokersNew England Journal of Medicine, 1994
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1988